Lv51
1450 积分 2023-03-16 加入
Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial
25天前
已完结
Repigmentation in non-segmental vitiligo using the Janus kinase inhibitor upadacitinib, a retrospective case series
25天前
已完结
Treatment of Persistent Erythema Multiforme With Janus Kinase Inhibition and the Role of Interferon Gamma and Interleukin 15 in Its Pathogenesis
26天前
已完结
Vitiligo
26天前
已完结
Systemic CXCL10 is a predictive biomarker of vitiligo lesional skin infiltration, PUVA, NB-UVB and corticosteroid treatment response and outcome
1个月前
已完结
624 - Vitiligo biomarker CXCL10 correlates with clinical response in the phase 2 randomized, double-blind, vehicle-controlled TRuE-V mechanism of action study
1个月前
已完结
Real-world effectiveness and safety of oral Janus kinase inhibitor in vitiligo: A retrospective study
1个月前
已完结
Safety and pharmacokinetics of SOR102, an oral bispecific inhibitor of TNF and interleukin-23 in healthy participants and patients with ulcerative colitis: a first-in-human, double-blind, randomised, placebo-controlled, phase 1 trial
1个月前
已完结
Design and Measurement of Drug Tissue Concentration Asymmetry and Tissue Exposure-Effect (Tissue PK-PD) Evaluation
3个月前
已完结
Comprehensive analysis of human IL‐4 receptor subunits shows compartmentalization in steady state and dupilumab treatment
4个月前
已完结
皖公网安备34019202002308
